abatacept 250 MG Injection [Orencia]
- RxCUI
- 616018
- RxNorm name
- abatacept 250 MG Injection [Orencia]
- Display name
- abatacept 250 MG Injection [Orencia]
- Full name
- abatacept 250 MG Injection [Orencia]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125118 | Orencia | abatacept | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ORENCIA | ABATACEPT | E.R. Squibb & Sons, L.L.C. | 0836c6ac-ee37-5640-2fed-a3185a0b16eb | 2025-11-13 | Warnings, Adverse reactions | 616018 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0836c6ac-ee37-5640-2fed-a3185a0b16eb | ORENCIA 250 MG Injection [PSN] · abatacept 250 MG Injection [Orencia] [SBD] · Orencia 250 MG Injection [SY] | 3 | 35 | These highlights do not include all the information needed to use ORENCIA safely and effectively. See full prescribing information for ORENCIA. ORENCIA (abatacept) for injection, for intravenous use ORENCIA (abatacept) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20251113 |